Reactivity of Pseudozyma antarctica lipase B towards the Synthesis of End-capped Polycaprolactone for Drug Delivery

Pedro R. Figueiredo,Armando J.D. Silvestre,Andreia F. Sousa,Alexandra T.P. Carvalho

DOI: https://doi.org/10.26434/chemrxiv-2024-pzclt

2024-07-23

Abstract:State-of-the-art delivery systems currently rely on chemical synthesis routes for drug encapsulation. However, these methods have inherent drawbacks concerning toxicity, selectivity, and the potential for burst release. To overcome these limitations, the enzymatic synthesis of polymer-drug conjugates emerges as a promising alternative to promote eco- friendliness and safety in production and grants precise control over the resulting structures. In this study, we delved into the reactivity of Pseudozyma (Candida) antarctica lipase B for polyesters’ capping with small molecules. For that purpose, Quantum Mechanics/Molecular Mechanics simulations were used to predict the conjugation reactions. These predictions were translated to the laboratory, where the enzymatic reactions were replicated, subsequently benchmarking them against metal-catalysed reactions. The outcome of our experiments was the successful generation of end-capped oligo/polycaprolactone, with their molecular weights spanning from 540 to 2600 g mol-1 with an enzymatic approach, and slightly higher when applying conventional catalysis, and with isolation yields up to 68.4%. This work underscores the potential of enzyme-driven strategies in fabricating precisely engineered drug delivery systems, marking a significant stride toward more efficient and controlled therapeutics synthesis.

Chemistry

What problem does this paper attempt to address?

The paper aims to address the issues present in current drug delivery systems, particularly the toxicity, poor selectivity, and potential burst release associated with chemical synthesis routes during drug encapsulation. To tackle these problems, researchers explored the application of Antarctic yeast lipase B (CalB) in the synthesis of small molecule-capped polycaprolactone (PCL), with the goal of developing an environmentally friendly and safe method to prepare precisely structured polymer-drug conjugates. By predicting reactions through quantum mechanics/molecular mechanics (QM/MM) simulations and validating these predictions in the laboratory, capped oligo/polycaprolactones with molecular weights ranging from 540 to 2600 g/mol were successfully generated, with yields reaching up to 68.4%. This work demonstrates the potential of enzymatic strategies in constructing precisely engineered drug delivery systems, marking an important step towards more efficient and controllable therapeutic drug synthesis.